These robust associations not only highlighted the clinical and therapeutic relevance of PAK1-driven angiogenesis in myxofibrosarcomas but also mirrored the contributions of overexpressed, activated, and nuclear PAK1 in promoting tumor growth, migration/invasion, and angiogenesis observed in vitro and in vivo. This evidence concerns the gene PAK1 and neoplasm.